[go: up one dir, main page]

PT623172E - Vacina de virus vaccinia recombinante do virus da doenca de marek - Google Patents

Vacina de virus vaccinia recombinante do virus da doenca de marek

Info

Publication number
PT623172E
PT623172E PT93902962T PT93902962T PT623172E PT 623172 E PT623172 E PT 623172E PT 93902962 T PT93902962 T PT 93902962T PT 93902962 T PT93902962 T PT 93902962T PT 623172 E PT623172 E PT 623172E
Authority
PT
Portugal
Prior art keywords
virus
marek
recombinant vaccinia
disease
disease virus
Prior art date
Application number
PT93902962T
Other languages
English (en)
Inventor
Enzo Paoletti
Taylor Jill
Tartaglia James
Louis Ross
Original Assignee
Virogenetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virogenetics Corp filed Critical Virogenetics Corp
Publication of PT623172E publication Critical patent/PT623172E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5256Virus expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16311Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24041Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
PT93902962T 1992-01-13 1993-01-07 Vacina de virus vaccinia recombinante do virus da doenca de marek PT623172E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82007792A 1992-01-13 1992-01-13
US139193A 1993-01-06 1993-01-06

Publications (1)

Publication Number Publication Date
PT623172E true PT623172E (pt) 2005-02-28

Family

ID=26668976

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93902962T PT623172E (pt) 1992-01-13 1993-01-07 Vacina de virus vaccinia recombinante do virus da doenca de marek

Country Status (10)

Country Link
EP (2) EP0623172B1 (pt)
JP (1) JP3706130B2 (pt)
AT (1) ATE286137T1 (pt)
AU (1) AU680609B2 (pt)
CA (1) CA2127700C (pt)
DE (1) DE69333728T2 (pt)
DK (1) DK0623172T3 (pt)
ES (1) ES2236684T3 (pt)
PT (1) PT623172E (pt)
WO (1) WO1993014219A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087127A (en) * 1990-08-24 2000-07-11 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
EP0696204A4 (en) * 1993-02-26 1999-03-31 Syntro Corp Recombined chickenpox virus and its use
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
AU2176997A (en) * 1996-03-29 1997-10-22 Nippon Zeon Co., Ltd. Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use
GB2460694A (en) * 2008-06-06 2009-12-09 Secr Defence Attenuated poxviruses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603112A (en) * 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
AU605567B2 (en) * 1987-03-11 1991-01-17 Nippon Zeon Co., Ltd. Recombinant avipoxvirus
DE10399031I1 (de) * 1987-08-28 2004-01-29 Health Research Inc Rekombinante Viren.
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
AU623913B2 (en) * 1988-06-24 1992-05-28 British Technology Group Limited Fowlpox virus non-essential regions
JP3339854B2 (ja) * 1988-09-13 2002-10-28 メリアル ウイルスワクチン
BE1004877A3 (fr) * 1991-05-27 1993-02-16 Solvay Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus.
DE69233080T2 (de) * 1991-06-14 2004-04-15 Connaught Technology Corp., Greenville Rekombinanter hiv-spezifischer impfstoff aus poxviru
US5369025A (en) * 1991-06-28 1994-11-29 The United States Of America As Represented By The Secretary Of Agriculture Recombinant fowlpox vaccine for protection against Marek's disease

Also Published As

Publication number Publication date
DK0623172T3 (da) 2005-04-25
DE69333728D1 (de) 2005-02-03
CA2127700A1 (en) 1993-07-22
JP3706130B2 (ja) 2005-10-12
ES2236684T3 (es) 2005-07-16
EP1489165A1 (en) 2004-12-22
CA2127700C (en) 2006-06-20
AU680609B2 (en) 1997-08-07
EP0623172A1 (en) 1994-11-09
AU3435393A (en) 1993-08-03
ATE286137T1 (de) 2005-01-15
JPH07503843A (ja) 1995-04-27
EP0623172B1 (en) 2004-12-29
DE69333728T2 (de) 2006-08-31
WO1993014219A1 (en) 1993-07-22
EP0623172A4 (en) 1995-08-09

Similar Documents

Publication Publication Date Title
IT9019623A0 (it) Sistema di selezione di spettro di infettivita' di poxvirus ricombinante
GB2269820A (en) Flavivirus recombinant poxvirus vaccine
IT9020063A0 (it) Vaccino di poxvirus ricombinante di herpesvirus
DK0592546T3 (da) Immundeficiens-virus rekombinant poxvirus-vaccine
DE3853088D1 (de) Rekombinantes Avipoxvirus.
DE68927025D1 (de) HIV-2-Virusvarianten
DE69016956D1 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
DK0523395T3 (da) Seroreaktive områder på proteinerne E1 og E2 i HPV 16
DE3888086D1 (de) Rekombinantes Geflügelpockenvirus, Expressionsvektoren für heterologische Proteine und davon derivierte Geflügelvakzine.
DE3850019D1 (de) Rekombinantes Avipoxvirus.
FR2620459B1 (fr) Virus recombinant de la vaccine
EP0597016A4 (en) Infectious bursal disease virus recombinant poxvirus vaccine.
DE69230627D1 (de) Rekombinantes Avipoxvirus
GB2264949A (en) Measles virus recombinant poxvirus vaccine
ATE117369T1 (de) Rekombinantes virus der marekschen krankheit und vakzin.
NO974322L (no) DNA som koder for human papillomvirus type 18
PT652287E (pt) Vectores de poxvirus e sua utilizacao contra doenca pelo virus da peritonite infecciosa felina
PT623172E (pt) Vacina de virus vaccinia recombinante do virus da doenca de marek
EP0486106A3 (en) Marek's disease virus vaccine
EP0759695A4 (en) METHOD FOR INDUCING AN IMMUNE RESPONSE BY MEANS OF RECOMBINANT VACCINIA VIRUSES
AU7890687A (en) DNA sequence vectors, recombinant viruses and method which employs recombinant vaccinia viruses capable of multiplying in CHO cells
NO881931L (no) Stabil, lyofilisert, levende herpesvirusvaksine.
EP0496787A4 (en) Novel infectious bursal disease virus
ATE165620T1 (de) Impfstoffe auf basis geänderter boviner herpesviren typ 1
AU2715288A (en) Human respiratory syncytialvirus vaccine derived from the 1a (9.5 kd) protein